# ZR-CHOP in DLBCL With Specific Gene Abnormality

> **NCT05290337** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 62 (estimated)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

- **DRUG:** zanubrutinib

## Key facts

- **NCT ID:** NCT05290337
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-04
- **Primary completion:** 2024-01-04
- **Final completion:** 2026-01-04
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2022-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05290337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05290337, "ZR-CHOP in DLBCL With Specific Gene Abnormality". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05290337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*